Cargando…
The Association of Glucocorticosteroid Treatment with WBC Count in Patients with COPD Exacerbation
Systematic glucocorticosteroids (GCS) are used to treat chronic obstructive pulmonary disease (COPD) and can cause leukocytosis. Distinguishing the effect of GCS on leukocyte level from infection-induced leukocytosis is important. We sought to quantify the effect of chronic GCS treatment on leukocyt...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6833099/ https://www.ncbi.nlm.nih.gov/pubmed/31623128 http://dx.doi.org/10.3390/jcm8101697 |
_version_ | 1783466301002350592 |
---|---|
author | Frenkel, Amit Kachko, Eric Novack, Victor Klein, Moti Brotfain, Evgeni Koyfman, Leonid Maimon, Nimrod |
author_facet | Frenkel, Amit Kachko, Eric Novack, Victor Klein, Moti Brotfain, Evgeni Koyfman, Leonid Maimon, Nimrod |
author_sort | Frenkel, Amit |
collection | PubMed |
description | Systematic glucocorticosteroids (GCS) are used to treat chronic obstructive pulmonary disease (COPD) and can cause leukocytosis. Distinguishing the effect of GCS on leukocyte level from infection-induced leukocytosis is important. We sought to quantify the effect of chronic GCS treatment on leukocytosis level in patients with COPD exacerbation. We reviewed the records of patients with COPD exacerbation and fever hospitalized in a tertiary medical center in 2003–2014. Patients were classified according to the GCS treatment they received: chronic GCS treatment (CST), acute GCS treatment (AST), and no prior GCS treatment (NGCS). We used the eosinophil absolute count as a marker of compliance and efficacy of steroid treatment. The primary outcome was the maximal white blood cell (WBC) count within the first 24 h of admission. Of 834 patients, 161 were categorized as CST, 116 AST, and 557 NGCS. The overall maximal leukocyte count was higher and the eosinophil count lower in the two GCS therapy groups. In patients with COPD exacerbation and fever, acutely treated with GCS, the mean increase in the WBC count was more evident when the eosinophils were undetectable (absolute count of zero). This supports leukocytosis level as a marker of disease course in COPD and fever. |
format | Online Article Text |
id | pubmed-6833099 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-68330992019-11-25 The Association of Glucocorticosteroid Treatment with WBC Count in Patients with COPD Exacerbation Frenkel, Amit Kachko, Eric Novack, Victor Klein, Moti Brotfain, Evgeni Koyfman, Leonid Maimon, Nimrod J Clin Med Article Systematic glucocorticosteroids (GCS) are used to treat chronic obstructive pulmonary disease (COPD) and can cause leukocytosis. Distinguishing the effect of GCS on leukocyte level from infection-induced leukocytosis is important. We sought to quantify the effect of chronic GCS treatment on leukocytosis level in patients with COPD exacerbation. We reviewed the records of patients with COPD exacerbation and fever hospitalized in a tertiary medical center in 2003–2014. Patients were classified according to the GCS treatment they received: chronic GCS treatment (CST), acute GCS treatment (AST), and no prior GCS treatment (NGCS). We used the eosinophil absolute count as a marker of compliance and efficacy of steroid treatment. The primary outcome was the maximal white blood cell (WBC) count within the first 24 h of admission. Of 834 patients, 161 were categorized as CST, 116 AST, and 557 NGCS. The overall maximal leukocyte count was higher and the eosinophil count lower in the two GCS therapy groups. In patients with COPD exacerbation and fever, acutely treated with GCS, the mean increase in the WBC count was more evident when the eosinophils were undetectable (absolute count of zero). This supports leukocytosis level as a marker of disease course in COPD and fever. MDPI 2019-10-16 /pmc/articles/PMC6833099/ /pubmed/31623128 http://dx.doi.org/10.3390/jcm8101697 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Frenkel, Amit Kachko, Eric Novack, Victor Klein, Moti Brotfain, Evgeni Koyfman, Leonid Maimon, Nimrod The Association of Glucocorticosteroid Treatment with WBC Count in Patients with COPD Exacerbation |
title | The Association of Glucocorticosteroid Treatment with WBC Count in Patients with COPD Exacerbation |
title_full | The Association of Glucocorticosteroid Treatment with WBC Count in Patients with COPD Exacerbation |
title_fullStr | The Association of Glucocorticosteroid Treatment with WBC Count in Patients with COPD Exacerbation |
title_full_unstemmed | The Association of Glucocorticosteroid Treatment with WBC Count in Patients with COPD Exacerbation |
title_short | The Association of Glucocorticosteroid Treatment with WBC Count in Patients with COPD Exacerbation |
title_sort | association of glucocorticosteroid treatment with wbc count in patients with copd exacerbation |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6833099/ https://www.ncbi.nlm.nih.gov/pubmed/31623128 http://dx.doi.org/10.3390/jcm8101697 |
work_keys_str_mv | AT frenkelamit theassociationofglucocorticosteroidtreatmentwithwbccountinpatientswithcopdexacerbation AT kachkoeric theassociationofglucocorticosteroidtreatmentwithwbccountinpatientswithcopdexacerbation AT novackvictor theassociationofglucocorticosteroidtreatmentwithwbccountinpatientswithcopdexacerbation AT kleinmoti theassociationofglucocorticosteroidtreatmentwithwbccountinpatientswithcopdexacerbation AT brotfainevgeni theassociationofglucocorticosteroidtreatmentwithwbccountinpatientswithcopdexacerbation AT koyfmanleonid theassociationofglucocorticosteroidtreatmentwithwbccountinpatientswithcopdexacerbation AT maimonnimrod theassociationofglucocorticosteroidtreatmentwithwbccountinpatientswithcopdexacerbation AT frenkelamit associationofglucocorticosteroidtreatmentwithwbccountinpatientswithcopdexacerbation AT kachkoeric associationofglucocorticosteroidtreatmentwithwbccountinpatientswithcopdexacerbation AT novackvictor associationofglucocorticosteroidtreatmentwithwbccountinpatientswithcopdexacerbation AT kleinmoti associationofglucocorticosteroidtreatmentwithwbccountinpatientswithcopdexacerbation AT brotfainevgeni associationofglucocorticosteroidtreatmentwithwbccountinpatientswithcopdexacerbation AT koyfmanleonid associationofglucocorticosteroidtreatmentwithwbccountinpatientswithcopdexacerbation AT maimonnimrod associationofglucocorticosteroidtreatmentwithwbccountinpatientswithcopdexacerbation |